Curis (CRIS) Change in Accured Expenses (2010 - 2026)
Curis (CRIS) reported Change in Accured Expenses of $521000.0 for Q1 2026, up 79.66% on a YoY basis from $290000.0 in Q1 2025, and down 62.71% quarter-over-quarter from $1.4 million in Q4 2025.
Curis (CRIS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Curis has reported Change in Accured Expenses for 17 years, with the latest figure at $521000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 79.66% year-over-year to $521000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 489.6% YoY), and the FY2025 full-year result was $2.5 million, up 222.58% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $521000.0, down from $1.4 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $4.0 million in Q3 2023, with the low at -$3.9 million in Q1 2022.
- Historically, Change in Accured Expenses has averaged $26235.3 across 5 years, with a median of $290000.0 in 2025.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 662.39% — and 2025, when it surged 178.31%.
- Curis' Change in Accured Expenses stood at -$3.7 million in 2022, then soared by 93.67% to -$234000.0 in 2023, then plunged by 662.39% to -$1.8 million in 2024, then surged by 178.31% to $1.4 million in 2025, then tumbled by 62.71% to $521000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $521000.0 (Q1 2026), $1.4 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 521,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 521,000.00 |
| Mar 31, 2026 | 521,000.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | -171,000.00 |
| Jun 30, 2025 | -171,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Sep 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | -816,000.00 |
| Jun 30, 2024 | -816,000.00 |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -234,000.00 |
| Dec 31, 2023 | -234,000.00 |